Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
Top Cited Papers
Open Access
- 1 December 2015
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 3 (12), 1344-1355
- https://doi.org/10.1158/2326-6066.cir-15-0097
Abstract
Dysfunctional T cells present in malignant lesions are characterized by a sustained and highly diverse expression of inhibitory receptors, also referred to as immune checkpoints. Yet, their relative functional significance in different cancer types remains incompletely understood. In this study, we provide a comprehensive characterization of the diversity and expression patterns of inhibitory receptors on tumor-infiltrating T cells from patients with non–small cell lung cancer. In spite of the large heterogeneity observed in the amount of PD-1, Tim-3, CTLA-4, LAG-3, and BTLA expressed on intratumoral CD8+ T cells from 32 patients, a clear correlation was established between increased expression of these inhibitory coreceptors and progression of the disease. Notably, the latter was accompanied by a progressively impaired capacity of T cells to respond to polyclonal activation. Coexpression of several inhibitory receptors was gradually acquired, with early PD-1 and late LAG-3/BTLA expression. PD-1 blockade was able to restore T-cell function only in a subset of patients. A high percentage of PD-1hi T cells was correlated with poor restoration of T-cell function upon PD-1 blockade. Of note, PD-1hi expression marked a particularly dysfunctional T-cell subset characterized by coexpression of multiple inhibitory receptors and thus may assist in identifying patients likely to respond to inhibitory receptor–specific antibodies. Overall, these data may provide a framework for future personalized T-cell–based therapies aiming at restoration of tumor-infiltrating lymphocyte effector functions. Cancer Immunol Res; 3(12); 1344–55. ©2015 AACR.Keywords
Other Versions
This publication has 46 references indexed in Scilit:
- T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?Nature Reviews Immunology, 2014
- Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cellsInternational Journal of Cancer, 2011
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunityThe Journal of Experimental Medicine, 2010
- Features of responding T cells in cancer and chronic infectionCurrent Opinion in Immunology, 2010
- Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedBlood, 2009
- Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral InfectionImmunity, 2007
- Decreased specific CD8+ T cell cross‐reactivity of antigen recognition following vaccination with Melan‐A peptideEuropean Journal of Immunology, 2006
- Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional ToleranceCancer Research, 2004
- Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional ImpairmentJournal of Virology, 2003
- Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector FunctionThe Journal of Experimental Medicine, 1998